DFSP poster presented at AACR 2015 annual meeting

It was great presenting some of our group’s work on dermatofibrosarcoma protuberans at the AACR meeting in Philadelphia. Find out here how we’ve identified CDK4 as a therapeutic target in imatinib-resistant DFSP, while establishing a novel laboratory model for this rare cutaneous sarcoma.